Anthera Pharmaceuticals

- NASDAQ:ANTH
Last Updated 2021-07-20
  • Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
  • Locations

    • Hayward CA
  • Total Funding (USD)

    65.5 million
  • Industries

    Real Estate, Mobile Apps, Cyber Security
  • Security

    Type: ORD
    CUSIP: 03674U300
    ISIN: US03674U3005
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.